Clinical Trials
3 trialsNCT02405273 2025-06-11
PUREAIR
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT04361552 2020-06-18
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
Emory University
Phase 3 Withdrawn
NCT00678405 2010-06-25
Trial of a Breathlessness Intervention Service for Intractable Breathlessness
Cambridge University Hospitals NHS Foundation Trust
Phase 3 Unknown